News & Events CTI to Present and Exhibit at ISPOR 19th Annual International Meeting

CTI to Present and Exhibit at ISPOR 19th Annual International Meeting

May 22, 2014

CTI Clinical Trial and Consulting Services to Present and Exhibit at ISPOR 19th Annual International Meeting

For Immediate Release [Cincinnati, OH ~ May 22, 2014]

CTI Clinical Trial and Consulting Services (CTI), an international, privately held, full-service contract research organization will present and exhibit at the ISPOR 19th Annual International Meeting in Montreal, May 31-June 4.

CTI has significantly expanded their Health Economic and Outcomes Research (HECOR) expertise through the acquisition of S2 Statistical Solutions in 2013. Not only have the commercial HECOR activities expanded, but HECOR strategies have been utilized more frequently as part of overall clinical development strategies with CTI’s more than 75 clients in the biotechnology, medical device, and pharmaceutical industries.

CTI will have posters presented at “Poster Session II”, Monday, June 2nd from 3:45pm-7:45pm; “Poster Session III”, Tuesday June 3rd from 8:30am-2:15pm; and at “Poster Session IV”, Tuesday June 3rd from 3:45pm-7:45pm.

Posters being presented at the sessions include: “The Variable Cost of an Operating Room Minute for Valvular Procedures” (Moore M, Mallow PJ, Rizzo JA), “Characterization of Ischemic Stroke Patients and Second Stroke Rates by Risk Scores” (Hunter TD, Quiroz ME, Gunnarsson C, Mollenkopf SA), “Incremental Burden of Anastomotic Leaks in Colorectal Surgeries” (Ghosh SK, Roy S, Ryan MP, Gunnarsson C, Yoo AC), “Economic Burden of Prolonged Air Leak after Lung Resection: Open versus Video Assisted Thoracoscopic Surgery (VATS)” (Swanson S, Miller D, McKenna R, Meyers B, Marshall MB, Ghosh SK, Fegelman E, Roy S, Ryan M, Gunnarsson C, Howington JA), “Outpatient Visits to the Cath Lab for Coronary Angiography Resulting in Minimal Action in the Short Term” (Mallow PJ, Rowlandson I, Tasic D), and “A Comprehensive Economic and Pricing Modeling Framework for Understanding Orphan Drug Development” (Mallow PJ, Rizzo JA, Irish W, Okere CE).

CTI will also exhibit throughout the meeting at booth #92.

According to the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), the society “promotes the science of pharmacoeconomics (health economics) and outcomes research (the scientific discipline that evaluates the effect of health care interventions on patient well-being, including clinical, economic, and patient-centered outcomes) and facilitates the translation of this research into useful information for health care decision makers to increase the efficiency, effectiveness, and fairness of health care to improve health.” ISPOR has over 7300 members from 105 countries.

About CTI Clinical Trial and Consulting Services

CTI Clinical Trial and Consulting Services is an innovative, international drug and device development organization that delivers a full spectrum of clinical trial and consulting services from bench to commercialization with a focus on immunology and a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology and startup firms with clinical and disease area expertise from a unique mix of academic, medical and industry specialists; rich intellectual capital in transplantation, immunology, infectious diseases, hematology, cardiology, nephrology, hepatology, regenerative medicine and rare diseases; flexible study designs that accelerate development programs and deliver high approval ratings that are among the best in the industry; and exceptional global project management and gold standard safety and data management systems that strengthen their program’s success potential. Established in 1999 and headquartered in Cincinnati, OH; CTI has offices in North America, Europe and South America.

Original Press Release

Subscribe to our mailing list

* indicates required